Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 235 results found. Search for [ free trials ]

Results 1 to 21 of 235
Reuters
December 5, 2020
Moscow's COVID-19 task force said the Russian-made vaccine would first be made available to doctors and other medical workers, teachers and social workers because they ran the highest risk of exposure to the disease


BusinessToday.In
December 4, 2020
Centre is presently conducting extensive backend preparation for  COVID-19 immunisation drive. Government expects to receive and utilise 400-500 million doses and cover around 20-25 crore people by July 21


PB Jayakumar
December 4, 2020
The company is also working with the USFDA to start an Investigational New Drug (IND) application for Pegylated Interferon alpha-2b in order to initiate clinical trials in US


BusinessToday.In
December 4, 2020
India Stock Market Highlights Today: During the session, Sensex touched a lifetime high of 45,148 and Nifty hit an all-time high of 13,280


BusinessToday.In
December 1, 2020
Balram Bhargava, Director General of Indian Council of Medical Research (ICMR), said that the primary objective of vaccination is to break the COVID-19 transmission chain


BusinessToday.In
November 30, 2020
There are only five companies that have given preliminary data about how effective their vaccines could be to fight against coronavirus. These five companies include Pfizer-BioTech, Moderna Inc, Oxford University-AstraZeneca Plc, and Gamaleya Institute


PB Jayakumar
November 28, 2020
Serum Institute will have a capacity to make over 2.5 billion doses of vaccines a year as it is currently upscaling the capacity from over 1.6 billion doses  


Manu Kaushik
New Delhi, November 25, 2020
The cloud kitchen business takes off as the pandemic changes the food and beverages landscape


PTI
November 24, 2020
The high court's order came on a plea by acquitted individual and Kusegaon Fruits and Vegetables Pvt Ltd director Asif Balwa that the CBI has not placed on record the mandatory authority under the provisions of the CrPC


BusinessToday.In
November 18, 2020
Narayana Murthy appealed to companies who can afford to bear the cost to give the vaccines for free. He also said that UN Security Council members should share a major part of this cos


PTI
November 17, 2020
Delhi Chief Minister Arvind Kejriwal on Tuesday said he is sending a proposal to the Centre to give power to Delhi government to impose lockdown in market areas which may emerge as COVID-19 hotspots


Yasmin Ahmed
New Delhi, November 16, 2020
The companies being targeted by cyberattacks belong to leading pharmaceutical companies and vaccine researchers in Canada, France, India, South Korea and the United States, according to Microsoft.


Reuters
November 13, 2020
Quarterly revenue slid 8% from the second quarter to $811 million (618 million pounds), while the company posted negative free cash flow of $517 million, less than $671 million of cash burn a quarter ago


PB Jayakumar
November 12, 2020
Zydus Cadila's Pegylated Interferon alpha-2b, PegiHep, was originally approved for Hepatitis C and was launched in the Indian market in 2011; it was repurposed for treating moderate COVID-19 patients


Shubham Verma
Kanpur, November 9, 2020
The Competition Commission of India has launched a probe against Google over multiple aspects, including the invariable promotion of Google Pay app in India.


Ankita Chakravarti
New Delhi, November 9, 2020
Online supermarket BigBasket landed in a soup recently when it accidentally put the data of over 2 crore users at stake.


PTI
October 31, 2020
Responding to a complaint by RTI activist Saket Gokhale, the commission said it has found no violation of the provisions of the model code in the issue


PTI
October 27, 2020
Speaking to reporters after a meeting with AstraZeneca Managing Director Gagan Singh Bedi, he said the first phase of trials of the vaccine were encouraging


PB Jayakumar & Joe C Mathew
October 26, 2020
Zydus Cadila's COVID-19 candidate vaccine ZyCov-D, which is currently undergoing second phase of clinical trials in India, is likely to enter Phase III final stage of clinical trials by December 2020


BusinessToday.In
New Delhi, October 26, 2020
Samsung's Lee Kun-hee leaves behind $21 billion wealth for inheritance; COVID-19 recovery rate in India touches 90%, only 8.5% of total caseload active; YES Bank aims to cut operational expenses by 20% in FY21. Watch this and more on News Blast. BT News Podcast: YES Bank aims to cut operational expenses by 20% in FY21


PAGES 1 OF 12  12345